The epimerization of avoparcin entities is discussed in some detail. The absolute stereochemistry of avoparcin is now known since the N-methyl terminal amino acid of the aglycone has been isolated and shown to exhibit negative optical rotation and hence has the R-configuration. The same amino acid has been isolated from an epimerized solution of avoparcin and found to have positive rotation and hence the S-configuration.
In the previous paper we outlined the isolation of most of the components of the avoparcin complex in relatively pure forms.') The structures of several of the minor components were also elucidated with a view towards obtaining further understanding of structure-activity relationship in this class of antibiotics. In this paper we describe in more detail the epimerization phenomenon of avoparcins. We have isolated an optically active form of the terminal p-hydroxyphenylsarcosine of avoparcin and the same amino acid with opposite rotation from epimerized avoparcin. Consequently we feel confident that the overall absolute configuration is as shown in Table 2 . There is considerable interest in the mode of action of this glycopeptide class of antibiotics at the present time. The mechanism involves the binding of N-terminal ends of the antibiotics to the D-ala-D-ala terminal portions of the cross-linking pentapeptide which plays a crucial role in the cell wall formation of bacteria. The net result is the proliferation of weak spots in the cell walls thus enhancing the possibility of cell lysis. The isolation of epi-3-avoparcin provides another useful tool for further study of this mechanism.
Stability and Epimerization Studies
If avoparcin is allowed to stand in solution at pH 4.0 or below, there is with time a decided increase in the amount of deristosaminyl compounds present. The use of lower pH's gives rise to CDP-I and mannosyl aglycone avoparcin." At pH's above 8.0 avoparcin begins to lose ammonia, probably from the benzylic ristosamine (latent 3-amino aldehyde) which is liberated by 3-elimination.') Above pH 9.5 methylamine is excised which is not surprising since from the EDMAN work we know that the methine carbon of the terminal amino acid is readily oxidized. All of these reactions are of course accelerated by heating. From such studies it appears that the pH range of maximum stability for the complex is between pH 4.0 and 8.0. However, if avoparcin is heated gently in aqueous solution in this pH range over a period of 3 to 18 hours, the antibacterial activity of the solution decreases dramatically. When epi-i3-avoparcin is subjected to the conditions described above, the same equilibrium is reached.
Evidence for the structure of epi-;3-avoparcin has already been reported3; other avoparcin entities were subjected to epimerization conditions and the reactions monitored by HPLC. Table 1 summarizes the results of these experiments.
In the case of the first seven entities, each of which has a mannose appendage the equilibrium ratios as well as the retention time ratios are fairly similar. The absence of mannose in s-avoparcin changes both ratios remarkably. Epimerization still occurs but now what is happening resembles a racemization. Apparently the mannose sugar is necessary for the extra stability of the diastereomer under equilibrium conditions. The deristosaminyl s-avoparcin was not isolated but a preparations were obtained where the amounts of this impurity were enhanced. The retention time of this minor component relative to that of 43-avoparcin was 1.08.
We have obtained CD curves on epi-;3-avoparcin and avoparcin for comparison purposes. The CD curve of 8 shows large peaks at 210 nm (Js -76.0) and 230 nm (Js-26.0) and a weak effect at 287 nm (Js -4.0).
The weak negative effect is attributable to a harmonic of the 1Lb band of the aromatic chromophores. A dramatic difference is observed in the CD curve of the epi-,3-avoparcin. The peak at 210 nm is the same as in the 13-compound (Js -49.2), however, the sign of the peak at 232 nm is reversed (Js -35.8). The weaker higher-wavelength harmonic effect remains about the same for both compounds (Js -4.5).
Reproductions of the CD curves of ,3 and epi-,3-avoparcins are shown in Fig. 1 . A similar reversal was noted with compounds X and Y4) In these compounds we have an extended conjugated carbonyl chromophore and a carboxyl chromophore whose chiroptic properties are dominated by vicinal asymmetric centers, one of which is reversed in X as opposed to Y. If we regard the avoparcin molecule as consisting of one extended large chromophore A adjacent to a single aromatic chro- reflected in the reversal of the 232 nm peak in the CD curve of the epi compound.
Our efforts were then directed to ascertaining the absolute configuration of the N-terminal phenylsarcosine amino acid. An EDMAN reaction was carried out on p-hydroxy-D-phenylglycine using standard conditions and the resultant thiohydantoin was optically inactive.5) Modification of the EDMAN conditions resulted in the isolation of an optically active product. Using those milder conditions CDP-I avoparcin was subjected to the first stage of the EDMAN method and processed to yield optically inactive thiohydantoins. When these attempts failed, we resorted to the method of LOMAKINA et al.6) which has also been successfully used by HARRIS et al. on ristocetin.7) Using this procedure on avoparcin we recovered crystalline N-methyl p-hydroxyphenylglycine which had a negative rotation in water. Consequently the configuration of the terminal amino acid in avoparcin is R in agreement with the configuration of the terminal amino acids in both vancomycin and ristocetin. p-Hydroxyphenylglycine from a-avoparcin and m-chloro p-hydroxyphenylglycine from ,3-avoparcin were also isolated from this hydrolysate. However in the former case the material was contaminated with about 20-25°o of the phydroxyphenylsarcosine and the second compound was unstable and subject to oxidation in our hands.
Nevertheless both preparations exhibited good positive rotation thus confirming the assignment of the 3' position as shown in Table 2 
Experimental
General Analytical and preparative HPLC work was carried out as described in the previous paper. NMR spectra were run on a Nicolet NT-300 WB while mass spectra were obtained using a Varian CH 7 spectrometer with an SS-100 Data System. CD curves were recorded in water with a Jasco J-40 spectropolarimeter at concentrations between 0.01 and 0.25 mg/ml. We thank Prof. K. NAKANISHI of Columbia University for these curves.
Isolation of Partially Deuterated epi-3-Avoparcin and 3-Avoparcin A solution containing 1 g of pure (3-avoparcin (98 % by HPLC) in 35 ml of D,O was adjusted to 6.8 using dilute NaOD solution and placed on the steam bath for 4 hours. At the end of that time HPLC analysis using a 50°C column temperature and 2.4 ml /minute pumping speed indicated that by UV area percent the solution contained 33 % ,3-avoparcin and 46%. epi-,3-avoparcin plus other impurities.
The reaction solution was diluted in 1 liter of HSA buffer and charged to a preparative column. After equilibration the column was eluted using 14 % CH;CN in HSA buffer to obtain two nicely resolved peaks. Fractions containing the first peak were processed to the first freeze-dried stage to yield 280 mg of a solid which dissolved in McOH.1' Addition of 0.5 mi (TEA)_H.SO, solution gave a precipitate which was processed to the second freeze-dried stage to yield 170 mg of white powder which was subsequently shown to be partially deuterated S-avoparcin since the 1' methine signal normally seen at 4.09 was completely missing.
[a]21 -94_2° (c 0.55, 0.1 N HC1).
The fractions of the second peak were handled in the same fashion to obtain 180 mg of partially deuterated epi-(3-avoparcin since the 1' methine proton visible in normal epi-,.3-avoparcin was missing from the 1H NMR spectrum of this preparation. The analytical HPLC trace on this material showed by UV area percent that it consisted of 83.4%. epi-5-avoparcin and approximately 10 % of other components. Preparation of e-Avoparcin Enriched in Deristosaminyl-e-avoparcin The isolation of e-avoparcin has been described in the previous paper. The heptane sulfonic acid salt of this material in concentrated aqueous solution was titrated with 10% aqueous sodium dodecyl sulfate (SDS) solution to a point just short of the end point. The s-avoparcin salt was removed by filtration and handled as described. The filtrate was then titrated with excess SDS solution. The precipitate from this stage was washed with H,O and taken up in methanol and the avoparcin material was precipitated using triethylamine sulfate [prepared as described in ref 1] . This solid recovered under these circumstances contained 20% of deristosaminyl-e-avoparcin in addition to e-avoparcin.
Epimerization Studies on Other Avoparcin Entities Epimerization studies were frequently carried out at concentrations of 1 or 2 mg/ml in the presence of equal concentrations of NaOAc. The pH was adjusted to the range of 4.0 to 8.0 as necessary. Frequently the NaOAc was omitted and the pH was simply adjusted to the desired value. The reaction solution was placed on top of the steam bath and allowed to sit for periods of from 3 to 18 hours. problems the CDP-I and mannosyl aglycone avoparcins could be run only at pH's below 5.0. On the other hand those entities with the attached disaccharide intact, if run at lower pH's (below 5.5), developed a plethora of peaks due to the generation of deristosaminyl compounds and their epimerized counterparts. Under all of these circumstances, however, there could be no mistaking the epimerization process occurring. Three individual epimerizations are discussed below in detail. A sample of a-avoparcin was heated overnight at pH 6.7 at a concentration of 2 mg/ml. After 18 hours the HPLC analytical trace showed that by UV area percent the solution contained material which was 23.3 % a-avoparcin and 56.9 % epi-a-avoparcin. When 0.25 ml of this reaction solution was added to 0.75 ml of 2 mg/ml of avoparcin, there was a decided enhancement of the minor peak (retention time 985 seconds) immediately following the major -peak (retention time 950 seconds). Consequently we are confident that this minor peak frequently detected in fermentations is epi-a-avoparcin. A 2 mg/ml solution of the mannosyl aglycone of avoparcin at pH 4.5 was heated overnight on the steam bath. The HPLC curve on the starting solution indicated that by UV area percent 17.2% of the material present was a-mannosyl aglycone and 76.2 % was 3-mannosyl aglycone. After overnight heating the trace on the reaction solution showed that by UV area percent the solution contained 7.3 % of a-mannosyl aglycone, 9.9 % of epi-a-mannosyl aglycone, 30.4 % of 3-mannosyl aglycone and 45.6 % epi-,;-mannosyl aglycone.
A 2 mg/ml solution of epi-;3-avoparcin was adjusted to pH 8.0 using dilute NaOH solution and left on the steam bath overnight. Comparison of the HPLC traces of the starting solution and the final reaction solution could be summed up as follows. The starting solution contained 87% epi-3-avoparcin and 1.5 % 3-avoparcin plus other minor peaks. The final reaction solution contained 20.5 % 3-avoparcin and 54 % epi-;3-avoparcin and some other minor peaks.
EDMAN Studies on D(-)-p-Hydroxyphenylglycine and CDP-I Avoparcin
Standard EDMAN degradation conditions involve the formation of a ureido derivative of the terminal amino acid of a peptide by stirring the peptide with isothiocyanate in pyridine -H2O, 50: 50 at pH 9.0. The ureido derivative is then cleaved and rearranged to a thiohydantoin by refluxing in dilute acid solution. When these conditions were applied to D(-)-p-hydroxyphenylglycine, we obtained a crystalline thiohydantoin, mp 228°C (melts to a red liquid), but which was optically inactive. The following modified conditions gave the optically active compound. A 1-g aliquot of D(-)-p-hydroxyphenylglycine was stirred in 60 ml of pyridine -HO, 1: 1 with the pH adjusted to 8.0. Then 2 ml of methylisothiocyanate was added and pH adjustment to 8.0 continued using I N NaOH solutions for 1.5 hours. The pH was then adjusted to 7.0 and the pyridine was evaporated off. The aqueous slurry was extracted with ether twice and the aqueous phase was desolventized and freeze-dried to 1.5 g of off-white solid which exhibited an [a]D -104 X0.5' (c 1.5, MeOH). About 0.75 g of this material was stirred in 50 ml of HOAc -6 N HCI, 4: 1 solution for two hours. The solution was diluted to 500 ml with H20 and extracted with EtOAc. The EtOAc extract was dried and concentrated and allowed to sit at room temperature to crystallize. About 200 mg of crystals, mp 210-212`C, were obtained in the first crop.
[a]i -116±1° (c 0.89, MeOH). MS m/z 222.
The first stage of the EDMAN reaction using the coupling conditions described above was applied to 2 g of CDP-I avoparcin. The pyridine was evaporated off and the excess isothiocyanate was removed using ether and the slurry was then extracted with EtOAc. The EtOAc extract upon concentration yielded 250 mg of a gum which was chromatographed on two thick-layer silica gel plates using the system CHCI, -MeOH, 9: 1. The plate exhibited major and minor UV absorbing bands very close together. The major band was processed to yield 95 mg of white crystals, mp 175-178°C, which had [a]25 0±0.5° (c 0.66, MeOH). A mass spectrum molecular ion was observed at m/z 252 which corresponds to the hydroxylated thiohydantoin.2) There was also a small peak at in/z 236 corresponding to the normal thiohydantoin.
Isolation of Optically Active Amino Acids from Avoparcin About 10 g of avoparcin sulfate was refluxed for 2 hours in 500 ml of I N HC1 solution. The reaction solution was neutralized to pH 6.5 and filtered and the residue was re-suspended in 500 ml of 2 N HCl solution and refluxed for 24 hours. The solution was neutralized to pH 6.0 using IR-45 (OH-) resin. After removal of resin the filtrate was percolated through a Pharmacia K15/30 column containing Dowex 50W X4 (H+ form, 100-200 mesh). After washing with H2O the column was eluted with a pyridine -acetate buffer (pH 4.7, 8 ml pyridine and 10 ml HOAc per liter H,O). In our hands this column failed to resolve this amino acid mixture.
The fractions containing the amino acids (as detected by ninhydrin and p-nitrobenzenediazonium fluoborate sprays) were combined and freeze-dried to 0.8 g of solid which was chromatographed over 500 g of an acid-washed Celite partition column using the system EtOAc -2-BuOH -HOAc -H2O, 1.5: 0.75: 0.75: 1. Fractions 18 through 20 were combined and concentrated to dryness. The residue was re-constituted in H2O, Darco treated, filtered and concentrated.
Upon standing the concentrate yielded 30 mg of white crystals, mp 252". 253~C.
[a]ll -72=4' (c 0.247, H,O). This material is about 52 % racemized.'2~ The El mass spectrum molecular ion at m/z 181 was weak. A large peak at m/z 136 (M'-COOH) was observed. 'H NMR (D2O) o 2.59 (s, NHCH,), 4.54 (s, methine proton), 6.96 and 7.3 (aromatic AB pair J=8.4, 4H). The rotation and spectroscopic data showed the material to be unequivocally N-CH.p-hydroxyphenylglycine (NCH,-p-OH-dgly) of the R configuration.e> The NMR curve indicated the presence of a few percent of p-hydroxyphenylglycine and also a percent or so of acetic acid. TLC on cellulose plates using the system 3-BuOH -HOAc -MO, 2: 1: 1 showed that one of the other two expected amino acids namely p-hydroxyphenylglycine (p-OH-,gly) was not resolved from the N-CH, amino acid. Nevertheless, fraction combinations were made to yield a preparation which consisted of 20-25 % NCH, p-OH-yigly and the remainderp-OH-ugly.
[a]2 +27_2° (c 0.79, H,O). EI mass spectrum molecular ion at m/z 167 was not detected. However, a large m/z 122 for [M+ -COOH] was observed as well as a peak at one quarter the intensity at m/z 136 for the impurity present. There was also a large peak at m/z 107 for HOOCH2. 'H NMR (D2O) 6 2.60 (s, NCH, impurity), 4.58 (1H methine of impurity), 4.73 (methine H) virtually hidden by water peak at 4.80, 6.96 and 7.23 aromatic AB pair of impurity, (these signals were about 1/4 intensity of signals at 7.00 and 7.38 (J=8 Hz) for four aromatic protons of p-OH-cgly). If we correct for the vitiating optical effect of the (-)NCH, p-OH-¢gly, the p-OH-rgly should exhibit an [a]D21 of +45' which is in fair agreement with the value of -43.5° cited by LOMAKINA et al.e) for the other enantiomer. The 3-chloro p-hydroxyphenylglycine (3-0-p-01-1-ugly) proved fairly elusive to isolate in our hands since it oxidized so readily. A yellow freeze-dried preparation of about 20 mg was obtained which had [a]U +32±2° (c 0.59, H2O). El mass spectrum molecular ion was not visible but did show a large peak at m/z 156 [M+-COON] showing the Cl isotope, also a large peak at m/z 141 for 3-Cl-HOOCH,+; 'H NMR (D,O) showed the presence of 50 mol % of (CH,), CHCH2OH and 20 mol % of HOAc; methine proton was hidden under water peak, aromatic region was clear-cut, AB pair at 7.12 and 7.52 (J=8 Hz) and proton adjacent to Cl at 7.30(J=8, 2 Hz). If we correct for impurities, the expected [a]D would be +48° which is slightly lower than LoMAKINA's value of -55' for the other enantiomer . Rf values of NCH, p-OH-¢gly, 3-Cl p-OH-¢gly and p-OH-ugly on cellulose using system 3-BuOH -HOAc -H2O, 2: 1: 1 are respectively 0.80, 0.75 and 0.65.
Isolation of Terminal Amino Acid from epi-Avoparcin About 8 g of epimerized avoparcin sulfate was processed as described in the previous experiment. From the partition column about 60 mg of chromatographically pure NCH, p-OH-¢gly were recovered. mp 257-258°C; [a]li ;-8_1° (c 0.98, 11.0); 1H NMR (D2O) o 2.58 (NCH;), 4.53 (methine H), 6.95 and 7.32 (J=8.4 Hz, aromatic 4H). We expected a higher rotation value but evidently the epimerization had not gone to equilibrium. Consequently there was a smaller excess of the epi compound. Nevertheless the data unequivocally shows that heating avoparcin overnight at 65°C causes inversion of the configuration of the terminal p-hydroxyphenylsarcosine. 
